长风药业2月10日耗资约37.05万港元回购1.05万股

Core Viewpoint - Changfeng Pharmaceutical (02652) announced a share buyback of approximately 10,500 shares at a cost of about HKD 370,500 on February 10, 2026 [1] Company Summary - The company executed a share repurchase, indicating a potential strategy to enhance shareholder value [1] - The total expenditure for the buyback was approximately HKD 370,500, reflecting the company's commitment to returning capital to shareholders [1]